Lumora

Company Overview

Snapshot

Founded in September 2025, Lumora operates with 1–10 employees. The company is currently in its Pre-Funding stage, focusing on developing an AI agent for clinical trial data validation.

Business overview

Lumora develops an AI agent designed to automate the end-to-end validation of clinical and trial data. Its platform ingests medical records and source files, learns study-specific datasets and rules, and generates protocol-aligned validation test plans. The technology autonomously detects data errors, traces them to originating documents, and suggests fixes, aiming to significantly reduce data-cleaning cycles, improve data quality, and accelerate regulatory readiness for sponsors and Contract Research Organizations (CROs). Lumora operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Clinical Workflow, targeting the B2B market.

Company Intelligence Q&A

What is Lumora's core technology?

Lumora's core technology is an AI agent that automates the validation of clinical and trial data, from ingesting medical records to generating validation test plans and detecting errors.

When was Lumora founded?

Lumora was founded in September 2025.

What problem does Lumora's AI agent solve?

Lumora's AI agent addresses the challenge of manual clinical data review by automating error detection, tracing, and suggested fixes, thereby reducing data-cleaning cycles and improving data quality for clinical operations and data management teams.

Which industries does Lumora serve?

Lumora primarily serves the Health Tech & Life Sciences sector, with a focus on Digital Healthcare and Clinical Workflow, catering to sponsors and Contract Research Organizations (CROs).

What is the current product stage of Lumora's offering?

Lumora's product is currently in its Beta stage, indicating that it is undergoing testing and refinement before a full commercial launch.